Results 161 to 170 of about 32,738 (290)

Correction to: Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience [PDF]

open access: bronze, 2019
Daniel Solomon   +16 more
openalex   +1 more source

Optimizing patient recovery: prospective study evaluating compliance and clinical outcomes of enhanced recovery protocols in ovarian cancer following cytoreductive surgery with HIPEC

open access: yesPleura and Peritoneum
To evaluate the implementation, compliance, and impact of the enhanced recovery after surgery (ERAS) protocol on perioperative outcomes in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for Stage ...
Somashekhar S. P.   +6 more
doaj   +1 more source

231 – Should We Be Doing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Signet Ring Cell Appendiceal Adenocarcinoma? a Study from the US Hipec Collaborative

open access: bronze, 2019
Nick C. Levinsky   +26 more
openalex   +1 more source

GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study [PDF]

open access: gold, 2014
Olivier Gléhen   +7 more
openalex   +1 more source

DISSEMINATED OVARIAN CANCER: MODERN APPROACH TO DRUG THERAPY (REVIEW OF PUBLISHED LITERATURE)

open access: yesСибирский онкологический журнал, 2016
The review presents data on drug therapy for ovarian cancer including neoadjuvant and intraperitoneal chemotherapy. The prospects of using targeted therapy for ovarian cancer are discussed.
S. V. Molchanov, L. A. Kolomiets
doaj  

Home - About - Disclaimer - Privacy